PATRICIA D TURNBOW FNP-BC NPI 1083852412

NPI Details

Patricia D Turnbow, FNP-BC is a family nurse practitioner in Amarillo, TX with 18 years of experience. Patricia D Turnbow, FNP-BC NPI is 1083852412. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a female.

The provider's business location address is:

400 SW 14TH AVE STE 100
AMARILLO, TX
ZIP 79101-140
Phone: (806) 337-4555
Fax: (806) 337-4551

The NPI 1083852412 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Injection, ceftriaxone sodium, per 250 mg (HCPCS:J0696)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month (HCPCS:99490)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Injection, triamcinolone acetonide, not otherwise specified, 10 mg (HCPCS:J3301)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Urinalysis, manual test (HCPCS:81002)
• Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza (HCPCS:87428)
• X-ray of chest, 2 views (HCPCS:71046)
• Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
• Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit (HCPCS:G0439)
• Administration of influenza virus vaccine (HCPCS:G0008)
• Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage (HCPCS:90686)
• Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen (HCPCS:87635)
• Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus (HCPCS:87426)
• Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) (HCPCS:87811)
• Automated urinalysis test (HCPCS:81003)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Detection test by nucleic acid for multiple types influenza virus (HCPCS:87502)
• New patient office or other outpatient visit, 30-44 minutes (HCPCS:99203)
• Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) (HCPCS:87880)
• Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report (HCPCS:93000)
• Removal of impacted ear wax (HCPCS:69210)
• Inhalation treatment for airway obstruction or sputum production (HCPCS:94640)
• Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg (HCPCS:J7613)
• Detection test by nucleic acid for strep (streptococcus, group a), amplified probe technique (HCPCS:87651)

The enumeration date for this NPI number is 1/22/2009 and was last updated on 5/19/2022.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available: